BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8033150)

  • 1. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
    Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
    Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
    Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
    Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
    Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
    Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
    Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma.
    Choy KW; Pang CP; Yu CB; Wong HL; Ng JS; Fan DS; Lo KW; Chai JT; Wang J; Fu W; Lam DS
    Hum Mutat; 2002 Nov; 20(5):408. PubMed ID: 12402348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
    Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of heterozygosity on chromosome RB1.20 locus and p110RB1 protein state in squmous cell carcinomas of larynx].
    Bai S; Fei S; Zhang X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Apr; 33(2):110-2. PubMed ID: 11498850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer.
    Tamura K; Zhang X; Murakami Y; Hirohashi S; Xu HJ; Hu SX; Benedict WF; Sekiya T
    Int J Cancer; 1997 Feb; 74(1):45-9. PubMed ID: 9036868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular study of first and second RB1 mutational hits in retinoblastoma patients.
    de Andrade AF; da Hora Barbosa R; Vargas FR; Ferman S; Eisenberg AL; Fernandes L; Bonvicino CR
    Cancer Genet Cytogenet; 2006 May; 167(1):43-6. PubMed ID: 16682285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.
    Kim TM; Benedict WF; Xu HJ; Hu SX; Gosewehr J; Velicescu M; Yin E; Zheng J; D'Ablaing G; Dubeau L
    Cancer Res; 1994 Feb; 54(3):605-9. PubMed ID: 8306317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
    Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
    Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.